ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.411,53
0,72%
S&P 500
6.118,71
0,53%
Dow Jones
44.565,07
0,92%
Euro vs US Dollar
1,0449
0,32%
Bitcoin
104.979,10
0,98%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Innoviva Inc (INVA)

  7. Innoviva Inc (INVA) News

INVA

Innoviva (INVA)

Innoviva Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INVA
DatumZeitQuelleÜberschriftSymbolFirma
16/12/202413h00Business WireInnoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)NASDAQ:INVAInnoviva Inc
26/11/202413h00Business WireInnoviva to Participate in the Citi 2024 Global Healthcare ConferenceNASDAQ:INVAInnoviva Inc
22/11/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
12/11/202422h05Business WireInnoviva to Participate in the UBS Global Healthcare ConferenceNASDAQ:INVAInnoviva Inc
06/11/202422h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVAInnoviva Inc
06/11/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
06/11/202422h05Business WireInnoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
04/09/202413h00Business WireInnoviva to Participate in Upcoming Investor ConferencesNASDAQ:INVAInnoviva Inc
22/08/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
31/07/202422h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVAInnoviva Inc
31/07/202422h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
31/07/202422h05Business WireInnoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
03/06/202413h00Business WireInnoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:INVAInnoviva Inc
22/05/202402h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
22/05/202402h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
13/05/202415h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
08/05/202422h46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVAInnoviva Inc
08/05/202422h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
08/05/202422h05Business WireInnoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
08/05/202413h00Business WireInnoviva to Participate in the BofA Securities Health Care ConferenceNASDAQ:INVAInnoviva Inc
24/04/202413h00Business WireInnoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024NASDAQ:INVAInnoviva Inc
08/03/202401h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/03/202401h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/03/202401h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/03/202400h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
29/02/202423h01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INVAInnoviva Inc
29/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
29/02/202422h05Business WireInnoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
23/02/202403h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
23/02/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
 Showing the most relevant articles for your search:NASDAQ:INVA

Kürzlich von Ihnen besucht

COIN
XRPUSD
Ripple
TG
CBK
Commerzbank
AMEX
XLV
Health Care Select Sector
COIN
AVAXUSD
Avalanche
TG
432
Arbor Metals
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
FX
EURUSD
Euro vs US Dollar
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
USOTC
RHHBY
Roche (QX)
TG
BAYN
Bayer
DBI
MDAX
MDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten